Michael Joseph Golembiewski
VP Finance, Controller, CAO, Pernix Therapeutics Holdings.
Companies
- Apricus BiosciencesChief financial officer Sep 2, 2021 to Mar 1, 20241
- Pernix Therapeutics HoldingsVP Finance, Controller, CAO Jun 1, 2015 to Aug 9, 20172
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Apricus Biosciences APRI86,869 shares3Feb 29, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 29, 2024Granted 417 shares at $1.10 of Apricus Biosciences3
- Nov 30, 2023Bought 83,000 shares at $1.21 of Apricus Biosciences4
- Aug 31, 2023Granted 12,500 shares at $0.62 of Apricus Biosciences5
- Feb 28, 2023Granted 12,500 shares at $0.67 of Apricus Biosciences6
- Feb 28, 2022Granted 12,500 shares at $0.90 of Apricus Biosciences7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Dec 1, 2023
- 5SEC EDGARForm 4 filed Sep 1, 2023
- 6SEC EDGARForm 4 filed Mar 2, 2023
- 7SEC EDGARForm 4 filed Mar 4, 2022